Adma Biologics (ADMA) FCF Margin Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) FCF Margin Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
4,709.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
4,709.00 |
| Sep 30, 2025 |
3,976.00 |
| Jun 30, 2025 |
3,770.00 |
| Mar 31, 2025 |
7,792.00 |
| Dec 31, 2024 |
10,790.00 |
| Sep 30, 2024 |
9,834.00 |
| Jun 30, 2024 |
24,669.00 |
| Mar 31, 2024 |
21,750.00 |
| Dec 31, 2023 |
27,884.00 |
| Sep 30, 2023 |
27,039.00 |
| Jun 30, 2023 |
31,531.00 |
| Mar 31, 2023 |
23,270.00 |
| Dec 31, 2022 |
15,424.00 |
| Sep 30, 2022 |
32,072.00 |
| Jun 30, 2022 |
23,861.00 |
| Mar 31, 2022 |
30,888.00 |
| Dec 31, 2021 |
41,595.00 |
| Sep 30, 2021 |
22,362.00 |
| Jun 30, 2021 |
12,479.00 |
| Mar 31, 2021 |
19,710.00 |
